Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.
Robert A FletcherWilliam G HerringtonRajiv AgarwalKaitlin J MayneClare ArnottMeg J JardineKenneth W MahaffeyVlado PerkovicNatalie StaplinDavid Collins WheelerGlenn M ChertowHiddo J Lambers HeerspinkBrendon L NeuenPublished in: Clinical journal of the American Society of Nephrology : CJASN (2024)
Clinical Trial registry name and registration number: ClinicalTrials.gov Identifiers: NCT02065791 (CREDENCE), NCT03036150 (DAPA-CKD), NCT03594110 (EMPA-KIDNEY).